Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Depreciation and Depletion (2024 - 2025)

CG Oncology's Depreciation and Depletion history spans 2 years, with the latest figure at $800000.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion changed N/A year-over-year to $800000.0; the TTM value through Dec 2025 reached $1.4 million, changed N/A, while the annual FY2025 figure was $1.4 million, 1300.0% up from the prior year.
  • Depreciation and Depletion reached $800000.0 in Q4 2025 per CGON's latest filing, up from $500000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $800000.0 in Q4 2025 to a low of $100000.0 in Q3 2024.